Qingdao Baheal Medical INC. (SHE:301015)
China
· Delayed Price · Currency is CNY 25.29
+1.16 (4.81%)
Apr 29, 2026, 1:45 PM CST
SHE:301015 Revenue
Qingdao Baheal Medical INC. had revenue of 1.78B CNY in the quarter ending March 31, 2026, a decrease of -3.10%. This brings the company's revenue in the last twelve months to 7.45B, down -7.89% year-over-year. In the year 2025, Qingdao Baheal Medical INC. had annual revenue of 7.51B, down -7.26%.
Revenue (ttm)
7.45B
Revenue Growth
-7.89%
P/S Ratio
1.67
Revenue / Employee
2.47M
Employees
3,064
Market Cap
12.68B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 7.51B | -587.94M | -7.26% |
| Dec 31, 2024 | 8.09B | -161.54M | -1.96% |
| Dec 31, 2023 | 8.26B | 746.38M | 9.94% |
| Dec 31, 2022 | 7.51B | 458.05M | 6.50% |
| Jan 1, 2022 | 7.05B | 1.17B | 19.94% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| China National Accord Medicines Corporation | 72.95B |
| China Meheco Group | 35.36B |
| C.Q. Pharmaceutical Holding | 82.27B |
| Liaoning Cheng Da | 9.90B |
| China National Medicines Corporation | 53.31B |
| Guangxi LiuYao Group | 20.95B |
| Jointown Pharmaceutical Group | 157.71B |
| Guangzhou Baiyunshan Pharmaceutical Holdings Company | 77.66B |